These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2757633)

  • 1. Stimulation of tumor necrosis factor-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction.
    Sakagami H; Ikeda M; Konno K
    Biochem Biophys Res Commun; 1989 Jul; 162(2):597-603. PubMed ID: 2757633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of interferon-gamma-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction.
    Kim F; Sakagami H; Tanuma S; Konno K
    Anticancer Res; 1990; 10(1):55-8. PubMed ID: 2110432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human peripheral blood polymorphonuclear cell iodination by PSK subfractions.
    Sakagami H; Kim F; Konno K
    Anticancer Res; 1990; 10(3):697-702. PubMed ID: 2369086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review).
    Sakagami H; Aoki T; Simpson A; Tanuma S
    Anticancer Res; 1991; 11(2):993-9. PubMed ID: 2064356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional maturation of monocytes/macrophages induced by PSK subfractions.
    Kurakata Y; Sakagami H; Sato A; Kikuchi K; Takeda M; Asano K; Sato T
    Anticancer Res; 1991; 11(5):1767-72. PubMed ID: 1768050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
    Mizutani Y; Nio Y; Yoshida O
    J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of differentiation-inducing factor and other cytokines on induction of differentiation of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M; Maurer HR; Okabe T; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):115-21. PubMed ID: 2470711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of guinea pig tumor necrosis factor (TNF): comparison of its antiproliferative and differentiative activities for myeloid leukemic cell lines with those of recombinant human TNF.
    Tamatani T; Kimura S; Hashimoto T; Onozaki K
    J Biochem; 1989 Jan; 105(1):55-60. PubMed ID: 2786869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic effect of PSK, a protein-bound polysaccharide, against the B16-BL6 mouse melanoma.
    Matsunaga K; Ohhara M; Oguchi Y; Iijima H; Kobayashi H
    Invasion Metastasis; 1996; 16(1):27-38. PubMed ID: 8830763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of arginase by mouse myeloid leukemic cell differentiation in vitro induced with tumor necrosis factor.
    Kosaka T; Kuwabara M; Endo A; Tamaguchi H; Koide F
    J Vet Med Sci; 1991 Feb; 53(1):53-7. PubMed ID: 1830780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview.
    Kobayashi H; Matsunaga K; Oguchi Y
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):275-81. PubMed ID: 7606203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
    Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
    Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of cytokine-induced human myelogenous leukemic cell differentiation on the type of serum in the medium.
    Sakagami H; Ikeda M; Fukushima Y; Konno K
    Anticancer Res; 1990; 10(2A):385-90. PubMed ID: 2111976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.
    Okabe-Kado J; Honma Y; Hayashi M; Hozumi M; Sampi K; Sakurai M; Hino K; Tsuruoka N
    Jpn J Cancer Res; 1988 Dec; 79(12):1318-26. PubMed ID: 3148602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by PSK of interleukin-1 production by human peripheral blood mononuclear cells.
    Sakagami H; Sugaya K; Utsumi A; Fujinaga S; Sato T; Takeda M
    Anticancer Res; 1993; 13(3):671-5. PubMed ID: 8317896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK.
    Kanoh T; Matsunaga K; Saito K; Fujii T
    In Vivo; 1994; 8(2):247-50. PubMed ID: 7522606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
    Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S
    Anticancer Res; 1992; 12(1):189-92. PubMed ID: 1567167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound polysaccharide isolated from basidiomycetes inhibits endotoxin-induced activation by blocking lipopolysaccharide-binding protein and CD14 functions.
    Asai Y; Takaori K; Yamamoto T; Ogawa T
    FEMS Immunol Med Microbiol; 2005 Jan; 43(1):91-8. PubMed ID: 15607641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of colony stimulating factors in mouse serum after injection of PSK, an antitumor polysaccharide.
    Satoh M; Ichimura O; Mitsuno T; Kojima E; Osawa T
    J Pharmacobiodyn; 1982 Oct; 5(10):818-28. PubMed ID: 6984462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.